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Effect of dialysis membrane and patient's age on signs of dialysis-
related amyloidosis. This 12 center study was designed to assess factors
affecting the development and progression of f32-microglobulin amyloi-
dosis in long-term dialysis. A total of 221 patients who were on
hemodialysis for more than five years, and who were treated the entire
time only with AN69, a biocompatible, highly permeable membrane, or
cuprophane, a less permeable, poorly biocompatible membrane (Cell)
were evaluated for time on dialysis, development of carpal tunnel
syndrome, and cystic bane lesions. X-ray documentation was taken in
a minimum of four of the six following joints: both hips, wrists and
shoulders. The data demonstrate that patients treated solely by AN69
membranes display signs of bone amyloidosis less frequently than do
those treated by Cell membranes. Age at onset of dialysis was found to
have a striking correlation with the development of carpal tunnel
syndrome and bone amyloidosis, while no significant influence was
found for hyperparathyroidism, sex or year of first dialysis.
/32-microglobulin (f32m) amyloidosis is a potentially crippling
complication of long-term dialysis. Its main clinical manifesta-
tions are related to the accumulation of aniyloid substance
within synovial membranes. They include the carpal tunnel
syndrome, swollen painful joints and bone defects with even-
tüal pathologic fractures [1].
The mechanism of 2m amyloid precipitation remains elu-
sive. Although elevated serum 132n1 appears to be a prerequisite,
it is by no means a sufficient condition [2]. Duration of dialysis
uridoubtedly favors the onset of dialysis amyloidosis [1]. It has
been further suggested [3] that the type of dialysis membrane
may also play a role: in a small series, amyloid bone lesions
analogous to those described in AL amyloidosis [4] were
encountered in patients dialyzed with cuprophane but not in
patients on AN69 (AN), a more biocompatible and porous
membrane. Similarly, the prevalence of carpal tunnel syndrome
(CTS) appeared higher in patients dialyzed mainly with cu-
prophane than in those treated solely with AN [5]. However,
these reports suffered from several limitations such as a small
number of patients included, inadequate follow-up or loose
selection criteria.
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A multicenter study was therefore undertaken first to assess
the influence of dialysis membranes on the prevalence of the
radiological signs of dialysis amyloidosis and carpal tunnel
syndrome, and second to look for other factors influencing the
onset of these two amyloid-related disorders. Only patients
dialyzed solely w.ith AN or with a cellulosic membrane were
included. The results demonstrate a highly significant effect of
membrane type on bone lesions and on the combination of CTS
and/or bone lesions. Independently of the membrane, age at the
onset of dialysis proved a highly significant risk factor.
Methods
Our aim was to identify patients on long-term (>5 years)
hemodialysis treated solely either by a highly permeable, bio-
compatible membrane, AN or by a less permeable, poorly
biocompatible cellulosic membrane (Cell). Centers known to
have patients on AN were asked to participate in the retrospec-
tive study.
The 12 centers who accepted filled a questionnaire for each
patient reporting age, sex, the membrane utilized as well as the
dates of the following events: switch from one type of mem-
brane to another even for a few weeks' vacation, transfer to
hemofiltration or CAPD, renal transplantation and death. The
occurrence and date of first surgical release of a carpal tunnel
syndrome and of parathyroidectomy were recorded. Results of
histological examination of tissue obtained during surgery for
carpal tunnel syndrome or bone fractures, by shoulder puncture
or at autopsy were provided. All available X-rays of shoulders,
hips, hands and wrists were forwarded to the coordinating
center.
Each questionnaire was critically reviewed by the coordinat-
ing center, was returned for further information whenever
necessary, and eventually sent back to each center for final
approval with the decision to retain or exclude the patient on
the basis of the inclusion criteria.
Inclusion criteria
A minimum of five years of treatment either on AN or on Cell
was required. A maximum of 10% of the dialysis duration,
never exceeding one year for the whole study, was allowed on
another membrane or another therapeutic modality. In fact, no
patient was temporarily transferred to hemofiltration or CAPD
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Fig. 1. This bone cyst (A) is observed in a patient dialyzed for 2 years. Its location in the upper third of the femoral neck is compatible with an
aspecific synovial inclusion (or herniation pit). It is thus not retained as evidence of bone amyloidosis. Its size remains stable for the subsequent
11 years (B). Between 1980 and 1983 (C) it grows rapidly. As a result, it is now considered as evidence of bone amyloidosis.
whereas five patients (1 AN, 4 Cell) received a renal transplant
lasting less than four months.
Adequate X-ray documentation was required and defined by
the availability of technically adequate anteroposterior views of
at least four of the six joints investigated in our study (both hips,
wrists and shoulders). Radiographic contrast, penetration and
patient positioning had to permit a satisfactory evaluation of
cystic bone lesions.
Observations were continued up to March 1, 1989 or to the
time of death or of sustained change in membrane or of
therapeutic modality, provided that an adequate X-ray docu-
mentation was available within less than six months before this
date. Otherwise, follow-up was interrupted at the date of the
last radiological assessment.
Patients with multiple myeloma were excluded.
From the submitted patients, 68 were eventually excluded for
excessive time on another treatment (N = 12 AN, 8 Cell),
inadequate time on a single membrane (N = 11 AN), insufficient
radiological documentation (N = 20 AN, 16 Cell) and for
multiple myeloma (N = 1 AN).
Radiological assessment
All X-rays were evaluated by a team of three skeletal
radiologists who ignored the type of membrane used by the
patient. "Amyloid" bone disease was diagnosed in a two step
process.
Individual lesions. Only bone defects with a diameter of at
least 10 mm in the shoulder and the hip and of 5 mm in the wrist
were taken into account. They had to be located outside areas
prone to have "synovial inclusions" (such as the upper third of
the femoral neck where it is called herniation pit [6] or the
anatomical humeral neck; Fig. 1A) and outside the weight-
bearing area of the joint (such as the outer third of the
acetabulum) (Fig. 2). A normal joint space adjacent to the
subchondral bone defect was required so as to exclude sub-
chondral bone cysts of osteoarthritic origin (Fig. 3). When
Fig. 2. Acetabular subchondral cyst in the weight-bearing part of the
hip, in a non-uremic patient. Such a cyst, despite its size, is not retained
as evidence of bone amyloidosis.
defects of an adequate size did not meet these latter criteria,
their growth rate during the preceding years was evaluated.
They were considered significant if their diameter increased by
more than 30% per year (Fig. 1B, C).
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Fig. 3. Multiple subchondral bone cysts in the wrist (black arrows) in a
patient dialyzed for 13 years. The ulnocarpal joint space is narrowed as
a consequence of a previous wrist fracture (open arrow). These cysts
are not retained as evidence of bone amyloidosis. They remained stable
over 4 years.
"Amyloid" bone disease was diagnosed when at least two
joints exhibited sign jflcant lesions. If the two joints were the
wrists, at least two significant lesions were required in one of
them (Fig. 4).
Twenty-one cystic bone lesions meeting the size criteria were
excluded. Nine (5 AN, 4 Cell) were discarded on the basis of
localization (outer third of the acetabulum 8, area of synovial
inclusion 1); six of them did not change in size throughout the
follow-up, whereas the other three (1 AN, 2 Cell) grew signifi-
cantly but no cyst appeared elsewhere. The other 12 lesions (6
AN, 6 Cell) were localized in a significant area but remained
unique until the end of the study. Their size did not change in
nine cases but increased in the last three (1 AN, 2 Cell).
In the absence of signs of bone amyloidosis (BA) on the last
follow-up, previous X-rays were not reviewed as BA is known
to progress relentlessly during dialysis [1]. If the last evaluation
disclosed BA, previous X-rays were analyzed to determine
when the criteria of BA were first met.
Statistical analysis
Comparisons were made during 180 months, the longest
follow-up in the AN group. Uni- and multivariate statistical
analyses were performed to study the following events: opera-
tion of CTS, radiological evidence of BA, parathyroidectomy
and death. Their occurrence was estimated by Kaplan-Meier
product limit method [7] and compared between both mem-
branes by log rank [8] and Gehan tests [9]. Cox proportional
hazards model [101 was used to assess the influence of mem-
brane type, age, sex, dialysis center or date of initiation of
dialysis (1978 or l979) on each outcome. Statistical signifi-
Fig. 4. Multiple carpal bone cysts without joint space narrowing in a
patient dialyzed for 11 years. These lesions, typical of bone amyloido-
sis, developed within less than 3 years.
cance of factors included in various models was evaluated by
Wald's likelihood ratio test [11]. Comparison between categor-
ical and numerical variables was done by chi-square and
Wilcoxon rank sum tests, respectively.
Results
The groups
A total of 221 patients were included (Table 1). The distribu-
tion of the diagnosis of renal disease was similar in the AN and
the Cell groups, respectively: glomerulonephritis 27% and 36%,
interstitial disease 26% and 23%, hypertension 14% and 7%,
hereditary nephropathy including polycystic kidneys 16% and
23%, diabetic nephropathy 7% and none, undetermined in 10%
and 11%. None of the eight diabetic patients developed carpal
tunnel syndrome or significant cystic bone lesions, Patients of
the AN group were older, started dialysis later and were
followed for a shorter period of time than the patients of the Cell
group. The proportion of male patients was lower in the AN
than in the Cell group.
Radiological evidence of hone amyloidosis
During the 180 months of follow-up, bone amyloidosis (BA)
was diagnosed in 20 patients (AN 3, Cell 17; 15 males, 5
females) after an average of 109 months (±31 SD, range 56 to
171) of dialysis at a mean age of 58 years (±9 SD,range 39 to 70).
Significant cysts were present in the wrists in all patients
(bilateral 13, unilateral 7), in the hips of 10 out of 19 patients
with adequate X-rays (bilateral 3, unilateral 7) and in the
shoulders of 5 out of 14 with adequate X-rays (bilateral 1,
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Table 1. Patient characteristics and recorded outcomes in two groups
of subjects dialyzed exclusively with either an AN69 or a cellulosic
membrane
AN Cell P
Number of patients 115 106
Sex ratio M/F 61/54 75/3 1 =0007b
Age (years) at the onset of 50.5 11.7 44.6 13.3 =0.0048
dialysis (mean SD)
Follow-up (months) 95.0 30.8 113.3 36.3 <o.oola
(mean SD)
First year on dialysis <0.0018
median 1979 1977
range (1973-1984) (1967—1983)
Bone amyloidosis 3 17
CTS surgery 6 12
CTS and/or bone 8 19
amyloidosis
Parathyroidectomy 20 26
Wilcoxon rank sum test
b Chi-square test
unilateral 4). In 19 patients, the median interval between the last
normal and the first positive X-rays was 12 months (range 8 to
86, mean 23 months 21 SD). In one patient (Cell group) no
X-ray was available before positive X-rays were obtained at 151
months.
Kaplan-Meier curves for the absence of bone amyloidosis are
presented for each group in Figure 5. They are significantly
better for the AN group (P = 0.003 for log rank, P = 0.013 for
Gehan test).
Cox model identified both age and membrane as independent
significant factors for this outcome (RR = 1.073, P = 0.004 and
RR = 5.559, P = 0.007 for age and membrane, respectively).
Inclusion of sex, initiation of dialysis 1978 versus  1979, or
single center failed to disclose a significant effect of these
factors (Table 2).
The best model (Table 2) provided the basis for a graphic
representation of the relative risk of radiological bone amyloi-
dosis as a function of the age at the initiation of dialysis and of
the utilized membrane (Fig. 6). In this figure, the risk of
developing the complication with AN for patients starting at age
20 is assumed to be one.
Operation for CTS
During the 180 months of follow-up, 18 CTS operations (AN
6, Cell 12) were performed in 15 males and 3 females after an
average of 108 months (±35SD, range 47 to 133) of dialysis at a
mean age of 61 years (±8 SD, range 44 to 73).
Kaplan-Meier curves without CTS operation are shown in
Figure 5 for the two groups. Various combinations of factors in
Cox models (membrane, age, sex, date of initiation of dialysis,
or single center) identified only age as a significant factor (Table
2-RR = 1.114, P < 0.001).
Evidence of bone amyloidosis and/or CTS
During the 180 months of follow-up, one and/or the other
event occurred in 27 patients (AN 8, Cell 19) after an average of
105 months on dialysis (±31 so, range 47 to 171) at a mean age
of 58 years (±9 so, range 39 to 70).
Kaplan-Meier curves without any of these events were sig-
nificantly better for the AN than for the Cell group (P = 0.050
by log rank, P = 0.029 by Gehan test). The Cox model identified
again age and membrane as separate significant variables influ-
encing this outcome (Table 2-RR = 1.077,P = 0.001 for age and
RR = 2.460, P = 0.035 for membrane, respectively). Neither
sex nor date of initiation of dialysis influenced this outcome
significantly.
Histologic evidence of amyloidosis
Histologic evaluation of tissue available in 14 of the 18 CTS
surgical releases (4 AN, 10 Cell) disclosed amyloid in only six
patients (1 AN, 5 Cell). The presence of f32m was confirmed by
immunohistology in all amyloid-positive tested samples (N =
5). Among patients with radiological evidence of BA, bone
and/or synovial tissue was also obtained during bone surgery,
by shoulder puncture or at autopsy in eight patients (all Cell).
Amyloid deposits were demonstrated in all. In all cases tested
by immunohistology (N = 6), f32m was identified. Overall,
amyloidosis was demonstrated histologically at one or more
sites in 11 patients with CTS surgery and/or BA.
Prevalence ofparathyroidectomy
During the 180 months of follow-up, 46 patients (20 AN, 26
Cell) underwent parathyroidectomy. The Kaplan-Meier curves
without parathyroidectomy were virtually identical in the two
groups. The Cox model identified only age as a determinant
negative factor (Table 2-RR = 0.972, P = 0.019), the older the
patient at the time of initiation of dialysis, the lower the risk of
parathyroidectomy.
Effect of membranes on survival
During the 180 months of follow-up, 11 and 14 patients died
respectively in the AN and Cell groups.
Kaplan-Meier curves did not differ between the two groups.
Multivariate analysis by Cox model identified only age as a
determinant factor of death (Table 2-RR = 1.076, P = 0.002).
Discussion
Our data demonstrate that the type of dialysis membrane
influences the development of large, multiple, cystic bone
lesions, tentatively labelled bone amyloidosis. The significance
of these results hinges upon the specificity of our radiologic
criteria for bone amyloidosis. Great care was taken to exclude
bone cysts associated with other, non-amyloid diseases. 1) The
size threshold required for considering bone cysts as significant
(diameter 5 mm in wrists and 10 mm in shoulders and hips)
excludes nonspecific small cysts present in up to 30% of
non-uremic patients [121. 2) The requirement of a normal joint
space adjacent to the bone defects excludes most subchondral
cysts due to osteoarthritis. 3) Cysts located in the weight
bearing area of the joint, as well as the defects of the "synovial
inclusion" type [61 observed in some sites were also discarded.
4) These various unspecific cystic lesions are characterized by
a very slow progression rate. Whenever their diameter in-
creased rapidly (that is, >30% per year) we retained them as
significant to keep a reasonable sensitivity of our criteria. 5)
Finally, to exclude bone cysts due to local diseases such as
pigmented villonodular synovitis [13] we required the presence
of cystic lesions in at least two joints.
The development of periarticular bone cysts in long-term
dialysis patients has sometimes been attributed to secondary
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hyperparathyroidism [14]. Several reasons mitigate against this
interpretation in the present series of patients. First, the criteria
of size and location of the lesions as well as the number of
involved joints probably exclude most or all hyperparathyroid
cystic lesions: brown tumors are not located preferentially in
the periarticular region and multiple brown tumors are unusual
in secondary hyperparathyroidism, only two cases being re-
ported, as far as we know, in uremic subjects [15, 16]. Second
the peculiar carpal defects (Fig. 4) present in all our patients
with bone amyloidosis have not been described in secondary
Fig. 6. Relative risk of developing radiological signs of bone amyloi-
dosisas a function of age at the initiation of dialysis either on AN69 (0)
or a cellulosic (A) membrane. The risk of developing the lesion with
AN69 for patients starting at age 20 is assumed to be one. Figures
derived from the best fitted model (Table 2).
hyperparathyroidism [17] and do not regress with hyperpara-
thyroidism after successful transplantation [181 or parathyroid-
ectomy [191. Finally, in our study, parathyroidectomy is signif-
icantly more frequent in young patients whereas bone
amyloidosis is more likely to develop in elderly subjects.
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Table 2. Best fitted Cox model for various outcomes in patients
dialyzed exclusively with an AN69 or a cellulosic membrane
Time, years
Fig. 5. Kaplan-Meier survival curves without carpal
tunnel syndrome (A) or without amyloid bone cysts
(B) in patients treated exclusively with either AN69
(—) or cellulosic membranes (). Survival without
amyloid bone cysts is significantly different for the 2
groups.
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The similarity of the bone lesions retained by our criteria with
those described in AL amyloidosis [4] suggests that they are
due to capsulosynovial amyloid infiltration. In both conditions
amyloid deposits seem to initially involve the synovial mem-
brane, to extend within capsule and ligaments with an attendant
articular soft tissue swelling and erosions in the bone margin
unprotected by a cartilaginous layer. The subchondral area is
initially spared. Subsequent amyloid infiltration may lead to the
intraosseous growth of marginal bone erosions and to the
invasion of pre-existing subchondral bone cysts through any
previous cartilage defects: in such case the rapid growth of the
cysts contrasts sharply with their previous stability (Fig. 1B,C).
Finally, as amyloid deposition is a non-inflammatory process,
marginal erosions remain limited, chondrolysis is absent and
joint space is well preserved.
No systematic pathologic confirmation of the amyloid nature
of the bone cysts was obtained in this retrospective study. Even
if attempted, it might have proved elusive, as it has been
recently shown by Ogawa that similar cystic lesions developing
in /32m amyloid infiltrated joints do not necessarily contain
amyloid but rather granulomatous tissue [20]. The presence of
132m amyloid in similar bone lesions has, however, been dem-
onstrated by several authors [1, 11, 21—24]. It is noteworthy that
in the present study material available in eight patients with
typical bone lesions always contained f32m amyloid.
Altogether, these arguments strongly suggest that the bone
lesions observed radiologically do result from f32m amyloidosis.
This evidence remains the best available at the present time to
assess dialysis-related amyloidosis and the factors contributing
to its development in a large population.
Our data demonstrate that, over the years, patients treated
solely by AN69 display signs of bone amyloidosis less fre-
quently than patients treated with a less porous, more bioin-
compatible cellulosic membrane. This difference can in no way
be attributed to differences in sex distribution or year of
initiation of dialysis. A center effect has also been excluded.
The retrospective character of our study precluded an analysis
of several other factors such as the type of dialyzer, dialysate
characteristics, serum iron or aluminum levels. Although on
theoretical grounds each of these factors has been considered,
none has yet been demonstrated to play a role in clinical
settings. The fact that 8 of the 12 participating centers contrib-
uted patients to both membrane groups decreases the likelihood
of a systematic bias for one of these parameters. Differences in
the degree of hyperparathyroidism are also unlikely: in addition
to the fact that the retained bone lesions do not reflect hyper-
parathyroidism, it is noteworthy that the prevalence of hyper-
parathyroidism as evidenced by parathyroidectomy is the same
in the AN and the Cell group.
Our conclusions contradict a recent report of the EDTA
Registry which compared the prevalence of periarticular cystic
lesions in patients dialyzed nine years or more by AN69 or a
cellulosic membrane [25]. Each participating physician was
asked to report whether or not periarticular bone cysts were
present without qualification for their size, number, location or
accompanying joint space abnormalities. The fact that bone
cysts are observed in 30% of non-uremic patients [12] casts
some doubt on the significance of such loosely defined abnor-
malities. Furthermore, no effort was made to define the timing
of appearance of the lesions and their rate of progression. In
addition, selection criteria qualifying for inclusion in the AN69
group were less stringent than in our study. Whereas we
allowed less than 10% of the time with a maximum of one year
on another membrane, the Registry accepted over two years in
one subgroup of 28 patients and up to two years in another
AN69 subgroup of 27 patients. Finally, radiological signs were
assessed 12 to 18 months alter inclusion in the two groups
without information on a possible switch of membranes in that
time. Yet, despite these shortcomings, the study reported a
suggestive though not statistically significant difference in the
prevalence of bone cysts: 38% in the cellulosic group versus
only 23% in the AN69 group receiving less than two years of
cellulosic dialysis.
The significance of CTS operation as a sign of f32m amyloi-
dosis is more debatable. Since Assenat et al's demonstration
[261 of amyloid deposits around the tendons in dialyzed patients
with the carpal tunnel syndrome, the high prevalence of this
complication in patients on long-term dialysis has usually been
attributed to f32m amyloidosis. It should not be forgotten,
however, that in '/3ofthe operated CTS no amyloid is found [1].
Although usually ascribed to an inadequate search for material
during the operation, this observation should remind us that
CTS is not an unusual disease in non-dialyzed patients and that
some of the recorded cases in our report may be unrelated to
32m amyloidosis. Furthermore, the criteria for surgery, the
terminal event retained in this multicenter study, may vary from
center to center and change over the years. It is therefore
possible that operation for CTS is a poor marker of f32m
amyloidosis.
No significant effect of membrane type on the prevalence of
CTS surgery was observed. This finding is at variance with the
report of Chanard et at [5] who reported a highly significant
difference in CTS prevalence according to the type of dialysis
membrane. Interestingly, in this study including 85 patients
treated for more than seven years, no carpal tunnel syndrome
was observed before 8.5 years whereas, in our study, we
recorded a prevalence of 3.7% at eight years, a value in keeping
with that of the literature [1, 27, 28]. Whether the discrepancy
between Chanard et a! and our study relates to our inclusion of
a greater number of non-amyloidosis CTS, thus blurring a
possible difference between the membrane groups or to a
difference in surgical treatment policies remains an open ques-
tion.
Whatever the explanation it is of interest that when all
patients with at least CTS operation or bone lesions are
considered, a statistically significant difference persists be-
tween the two membrane groups.
One of the most striking observations of our study is the
marked influence of age on the development of both the carpal
tunnel syndrome and bone amyloidosis. Although it is known
that age is associated with senile amyloidosis [29], there is at
present no obvious explanation for our observations. Possible
mechanisms include an age-related impairment in the ability to
dissolve aggregated fibrils, an effect on macrophage production
of the actual j32m fibrils, an increase in some co-precipitating
factor or alteration of glycosaminoglycans metabolism [30].
Whatever its cause, this relationship draws the attention on age
as a critical factor in any prospective study trying to elucidate
the effect of amyloidogenic factors in dialysis-related amyloi-
dosis.
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Both the effect of age and membrane on dialysis amyloidosis
may be taken into consideration for membrane prescription. It
is quite apparent from Figure 4 that young people are less liable
to this complication. As this patient category is also the one that
is most likely to be transplanted after only a few years on
dialysis, this group would benefit little from an amyloid sparing
membrane. On the other hand the increasing cohort of elderly
patients unlikely to be transplanted might be protected from
bone amyloidosis by a membrane such as AN69.
Whether the conclusions drawn from AN69 apply to other
equally porous or equally biocompatible membranes remains a
yet to be tested hypothesis. Indeed, at the present time it is not
clear why AN69 is associated with a lower frequency of
amyloid bone disease: it might be related to a better clearing of
J32m, to an improved removal of antiproteases capable to inhibit
2m catabolism [311, to an improved biocompatibility or to
another hitherto unknown phenomenon. Finally, it should be
pointed out that although our observations extend to 15 years,
the number of patients at risk in both groups decreases sharply
over time. It remains thus to be established whether our
observations also apply for very long survivals on hemodialy-
sis.
Summary
Periarticular bone lesions and the carpal tunnel syndrome
(CTS) are two clinical expressions of dialysis-related amyloido-
sis. Our multicentric study was undertaken to assess retrospec-
tively their prevalence over time and to evaluate contributing
factors such as dialysis membranes, age, sex and hyperparathy-
roidism.
Two groups of patients dialyzed for more than five years
solely by either a cellulosic (N = 106) or by a polyacrilonitrile
(AN69) membrane (N = 115) were compared for up to 180
months. Operation for carpal tunnel syndrome and parathyroid-
ectomy were recorded. Radiological signs of bone amyloidosis
defined by precise criteria were evaluated by a single team of
radiologists.
Prevalence over time of either bone amyloidosis or CTS or a
combination of both was described by Kaplan-Meier survival
curves without the event. The Cox proportional hazards model
was used to evaluate independent contributing factors. Radio-
logical signs of bone amyloidosis were significantly influenced
by membranes, AN69 being better than cellulosic (P = 0.007),
and by age (P = 0.004), younger faring better than older
patients. Carpal tunnel syndrome was influenced only by age (P
< 0.001). The combination of bone lesions and/or CTS also
depended on membranes (P = 0.035) and age (P = 0.001). No
effect of sex, year of first dialysis was demonstrable. Prevalence
over time of hyperparathyroidism as evidenced by parathyroid-
ectomy was the same in the two membrane groups and influ-
enced only by age (P = 0.019), older patients being less liable to
the operation.
Thus, the development of bone amyloidosis appears signifi-
cantly influenced by membrane characteristics and age, but
independent of hyperparathyroidism, sex and year of first
dialysis.
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